Drugs face cost-effectiveness trial after study approves cholesterol busters
A major study found that the drugs, known as statins, pass the cost-effectiveness test when it comes to curing the patient without killing the taxpayer.
Now every newly available drug is to be put through a similar test before being subsidised under the Community Drugs Scheme, while many available under the scheme will be assessed.